Christer Tannergren, PhD, Principal Scientist in Biopharmaceutics at Oral Product Development, Pharmaceutical Technology & Development, AstraZeneca Gothenburg, Sweden. He received his PhD in Biopharmaceutics at the Department of Pharmacy, Uppsala University, Sweden in 2004. He has held various Biopharmaceutics expert positions and Product Development Lead roles since joining AstraZeneca in 2003. His main areas of research interest include physiologically based biopharmaceutics modelling and regional intestinal absorption/bioavailability as well as development of low solubility and Modified Release drug products. He has co-supervised 3 PhD students and is author of 35 peer-reviewed papers as well as inventor of 1 formulation patent.
Don't miss
- Best lecture (runner-up) award at the SoP Research Day goes to COLOTAN’s Alessia!
- Alessia won 2nd place in the “Explore your Entrepreneurial Idea” program!
- COLOTAN published an article on the development of a canine artificial colonic mucus model for drug diffusion studies
- A review on solidification and oral delivery of biologics to the colon
- Pedro Canhão Costa is nominated as best presenter at the 2023 Johnson & Johnson Global Science Symposium